Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Glucosylsphingosine

😃Good
Catalog No. T78493Cas No. 52050-17-6
Alias Lyso-Gb1, Glucosyl-C18-sphingosine, Glucopsychosine, 1-β-D-Glucosylsphingosine

Glucosylsphingosine (Lyso-Gb1) is a naturally occurring glycosyl ceramide, a metabolite of GBA (acid β-glucosidase), involved in cellular recognition, signaling, and intercellular interactions.Glucopsychosine accumulates in certain neurodegenerative diseases (e.g., Gaucher disease), disrupts lysosomal function through activation of mammalian target of rapamycin complex 1 (mTORC1), and is a noncompetitive inhibitor of glucocerebrosidase.

Glucosylsphingosine

Glucosylsphingosine

😃Good
Catalog No. T78493Alias Lyso-Gb1, Glucosyl-C18-sphingosine, Glucopsychosine, 1-β-D-GlucosylsphingosineCas No. 52050-17-6
Glucosylsphingosine (Lyso-Gb1) is a naturally occurring glycosyl ceramide, a metabolite of GBA (acid β-glucosidase), involved in cellular recognition, signaling, and intercellular interactions.Glucopsychosine accumulates in certain neurodegenerative diseases (e.g., Gaucher disease), disrupts lysosomal function through activation of mammalian target of rapamycin complex 1 (mTORC1), and is a noncompetitive inhibitor of glucocerebrosidase.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$49535 days35 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Glucosylsphingosine (Lyso-Gb1) is a naturally occurring glycosyl ceramide, a metabolite of GBA (acid β-glucosidase), involved in cellular recognition, signaling, and intercellular interactions.Glucopsychosine accumulates in certain neurodegenerative diseases (e.g., Gaucher disease), disrupts lysosomal function through activation of mammalian target of rapamycin complex 1 (mTORC1), and is a noncompetitive inhibitor of glucocerebrosidase.
In vitro
Methods: MCF7 cells were treated with glucosylsphingosine (20-45 μM, 48 hours), and cell death was determined by PI and Hoechst-33342 staining.
Results: Glucosylsphingosine killed MCF7 cells independently of apoptosis, ferroptosis, and necroptosis, and induced cell death in a dose-dependent manner, with an LC50 of 33 μM.[4]
In vivo
Methods: Adult male C57BL/6JRj mice were treated with glucosylsphingosine (10 mg/kg, subcutaneous injection, daily, for 12 consecutive weeks) and the inflammatory changes in the mice were observed.
Results: Glucosylsphingosine accumulated in peripheral tissues and induced hematological symptoms in mice, such as decreased hemoglobin and hematocrit, increased spleen weight, and mild inflammatory tissue reactions, indicating that it induced visceral inflammatory reactions in mice. [6]
SynonymsLyso-Gb1, Glucosyl-C18-sphingosine, Glucopsychosine, 1-β-D-Glucosylsphingosine
Chemical Properties
Molecular Weight461.63
FormulaC24H47NO7
Cas No.52050-17-6
SmilesO(C[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)N)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 100 mg/mL (216.62 mM), Sonication is recommended.
DMSO: 80 mg/mL (173.3 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (7.15 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM2.1662 mL10.8312 mL21.6624 mL108.3119 mL
5 mM0.4332 mL2.1662 mL4.3325 mL21.6624 mL
10 mM0.2166 mL1.0831 mL2.1662 mL10.8312 mL
20 mM0.1083 mL0.5416 mL1.0831 mL5.4156 mL
50 mM0.0433 mL0.2166 mL0.4332 mL2.1662 mL
100 mM0.0217 mL0.1083 mL0.2166 mL1.0831 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Glucosylsphingosine | purchase Glucosylsphingosine | Glucosylsphingosine cost | order Glucosylsphingosine | Glucosylsphingosine chemical structure | Glucosylsphingosine in vivo | Glucosylsphingosine in vitro | Glucosylsphingosine formula | Glucosylsphingosine molecular weight